Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Sep 21;161(6):717–724.

Tuberculosis: 10. Prevention

D Menzies 1, T N Tannenbaum 1, J M FitzGerald 1
PMCID: PMC1230622  PMID: 10513279

Full Text

The Full Text of this article is available as a PDF (238.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adhikari N., Menzies R. Community-based tuberculin screening in Montreal: a cost-outcome description. Am J Public Health. 1995 Jun;85(6):786–790. doi: 10.2105/ajph.85.6.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adhikari N., Menzies R. Community-based tuberculin screening in Montreal: a cost-outcome description. Am J Public Health. 1995 Jun;85(6):786–790. doi: 10.2105/ajph.85.6.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Colditz G. A., Brewer T. F., Berkey C. S., Wilson M. E., Burdick E., Fineberg H. V., Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994 Mar 2;271(9):698–702. [PubMed] [Google Scholar]
  4. Comstock G. W. Frost revisited: the modern epidemiology of tuberculosis. Am J Epidemiol. 1975 May;101(5):363–382. doi: 10.1093/oxfordjournals.aje.a112105. [DOI] [PubMed] [Google Scholar]
  5. Dash L. A., Comstock G. W., Flynn J. P. Isoniazid preventive therapy: Retrospect and prospect. Am Rev Respir Dis. 1980 Jun;121(6):1039–1044. doi: 10.1164/arrd.1980.121.6.1039. [DOI] [PubMed] [Google Scholar]
  6. Donaldson J. C., Elliott R. C. A study of co-positivity of three multipuncture techniques with intradermal PPD tuberculin. Am Rev Respir Dis. 1978 Nov;118(5):843–846. doi: 10.1164/arrd.1978.118.5.843. [DOI] [PubMed] [Google Scholar]
  7. Edwards L. B., Acquaviva F. A., Livesay V. T., Cross F. W., Palmer C. E. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis. 1969 Apr;99(4 Suppl):1–132. [PubMed] [Google Scholar]
  8. Fine P. E., Sterne J. A., Pönnighaus J. M., Rees R. J. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet. 1994 Nov 5;344(8932):1245–1249. doi: 10.1016/s0140-6736(94)90748-x. [DOI] [PubMed] [Google Scholar]
  9. Fitzgerald J. M., Gafni A. A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test. Am Rev Respir Dis. 1990 Oct;142(4):848–853. doi: 10.1164/ajrccm/142.4.848. [DOI] [PubMed] [Google Scholar]
  10. Fry K. L., Meissner P. S., Falkinham J. O., 3rd Epidemiology of infection by nontuberculous mycobacteria. VI. Identification and use of epidemiologic markers for studies of Mycobacterium avium, M. intracellulare, and M. scrofulaceum. Am Rev Respir Dis. 1986 Jul;134(1):39–43. doi: 10.1164/arrd.1986.134.1.39. [DOI] [PubMed] [Google Scholar]
  11. Graham N. M., Nelson K. E., Solomon L., Bonds M., Rizzo R. T., Scavotto J., Astemborski J., Vlahov D. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA. 1992 Jan 15;267(3):369–373. [PubMed] [Google Scholar]
  12. Grzybowski S., Barnett G. D., Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc. 1975;50(1):90–106. [PubMed] [Google Scholar]
  13. Grzybowski S., Fishaut H., Rowe J., Brown A. Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service. Am Rev Respir Dis. 1971 Oct;104(4):605–608. doi: 10.1164/arrd.1971.104.4.605. [DOI] [PubMed] [Google Scholar]
  14. Halsey N. A., Coberly J. S., Desormeaux J., Losikoff P., Atkinson J., Moulton L. H., Contave M., Johnson M., Davis H., Geiter L. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet. 1998 Mar 14;351(9105):786–792. doi: 10.1016/S0140-6736(97)06532-X. [DOI] [PubMed] [Google Scholar]
  15. Hanson M. L., Comstock G. W. Efficacy of hydrocortisone ointment in the treatment of local reactions to tuberculin skin tests. Am Rev Respir Dis. 1968 Mar;97(3):472–473. doi: 10.1164/arrd.1968.97.3.472. [DOI] [PubMed] [Google Scholar]
  16. Hershfield E. Tuberculosis: 9. Treatment. CMAJ. 1999 Aug 24;161(4):405–411. [PMC free article] [PubMed] [Google Scholar]
  17. Holden M., Dubin M. R., Diamond P. H. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med. 1971 Dec 30;285(27):1506–1509. doi: 10.1056/NEJM197112302852704. [DOI] [PubMed] [Google Scholar]
  18. Howard W. L., Klopfenstein M. D., Steininger W. J., Woodruff C. E. The loss of tuberculin sensitivity in certain patients with active pulmonary tuberculosis. Chest. 1970 Jun;57(6):530–534. doi: 10.1378/chest.57.6.530. [DOI] [PubMed] [Google Scholar]
  19. Johnson H., Lee B., Doherty E., Kelly E., McDonnell T. Tuberculin sensitivity and the BCG scar in tuberculosis contacts. Tuber Lung Dis. 1995 Apr;76(2):122–125. doi: 10.1016/0962-8479(95)90553-7. [DOI] [PubMed] [Google Scholar]
  20. Joncas J. H., Robitaille R., Gauthier T. Interpretation of the PPD skin test in BCG-vaccinated children. Can Med Assoc J. 1975 Jul 26;113(2):127–128. [PMC free article] [PubMed] [Google Scholar]
  21. Kirschner R. A., Jr, Parker B. C., Falkinham J. O., 3rd Epidemiology of infection by nontuberculous mycobacteria. Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum in acid, brown-water swamps of the southeastern United States and their association with environmental variables. Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):271–275. doi: 10.1164/ajrccm/145.2_Pt_1.271. [DOI] [PubMed] [Google Scholar]
  22. Kopanoff D. E., Snider D. E., Jr, Caras G. J. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis. 1978 Jun;117(6):991–1001. doi: 10.1164/arrd.1978.117.6.991. [DOI] [PubMed] [Google Scholar]
  23. Koplan J. P., Farer L. S. Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique. JAMA. 1980 Dec 19;244(24):2736–2740. [PubMed] [Google Scholar]
  24. Lincoln E. M. Epidemics of tuberculosis. Bibl Tuberc. 1965;21:157–201. [PubMed] [Google Scholar]
  25. Lotte A., Wasz-Höckert O., Poisson N., Dumitrescu N., Verron M., Couvet E. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res. 1984;21:107–193. [PubMed] [Google Scholar]
  26. Lunn J. A., Johnson A. J., Fry J. S. Comparison of multiple puncture liquid tuberculin test with Mantoux test. Lancet. 1981 Mar 28;1(8222):695–698. doi: 10.1016/s0140-6736(81)91974-7. [DOI] [PubMed] [Google Scholar]
  27. Markowitz N., Hansen N. I., Wilcosky T. C., Hopewell P. C., Glassroth J., Kvale P. A., Mangura B. T., Osmond D., Wallace J. M., Rosen M. J. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med. 1993 Aug 1;119(3):185–193. doi: 10.7326/0003-4819-119-3-199308010-00002. [DOI] [PubMed] [Google Scholar]
  28. Menzies D. Effect of treatment on contagiousness of patients with active pulmonary tuberculosis. Infect Control Hosp Epidemiol. 1997 Aug;18(8):582–586. doi: 10.1086/647678. [DOI] [PubMed] [Google Scholar]
  29. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999 Jan;159(1):15–21. doi: 10.1164/ajrccm.159.1.9801120. [DOI] [PubMed] [Google Scholar]
  30. Menzies R., Rocher I., Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tuber Lung Dis. 1993 Feb;74(1):32–37. doi: 10.1016/0962-8479(93)90066-7. [DOI] [PubMed] [Google Scholar]
  31. Menzies R., Vissandjee B., Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis. 1992 Sep;146(3):752–756. doi: 10.1164/ajrccm/146.3.752. [DOI] [PubMed] [Google Scholar]
  32. Menzies R., Vissandjee B. Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992 Mar;145(3):621–625. doi: 10.1164/ajrccm/145.3.621. [DOI] [PubMed] [Google Scholar]
  33. Nardell E. A. Dodging droplet nuclei. Reducing the probability of nosocomial tuberculosis transmission in the AIDS era. Am Rev Respir Dis. 1990 Sep;142(3):501–503. doi: 10.1164/ajrccm/142.3.501. [DOI] [PubMed] [Google Scholar]
  34. Nolan C. M., Elarth A. M. Tuberculosis in a cohort of Southeast Asian Refugees. A five-year surveillance study. Am Rev Respir Dis. 1988 Apr;137(4):805–809. doi: 10.1164/ajrccm/137.4.805. [DOI] [PubMed] [Google Scholar]
  35. Orr P. H., Manfreda J., Hershfield E. S. Tuberculosis surveillance in immigrants to Manitoba. CMAJ. 1990 Mar 1;142(5):453–458. [PMC free article] [PubMed] [Google Scholar]
  36. POULSEN A. Some clinical features of tuberculosis. 1. Incubation period. Acta Tuberc Scand. 1950;24(3-4):311–346. [PubMed] [Google Scholar]
  37. Pesanti E. L. The negative tuberculin test. Tuberculin, HIV, and anergy panels. Am J Respir Crit Care Med. 1994 Jun;149(6):1699–1709. doi: 10.1164/ajrccm.149.6.7710481. [DOI] [PubMed] [Google Scholar]
  38. RILEY R. L. Aerial dissemination of pulmonary tuberculosis. Am Rev Tuberc. 1957 Dec;76(6):931–941. doi: 10.1164/artpd.1957.76.6.931. [DOI] [PubMed] [Google Scholar]
  39. Rodrigues L. C., Diwan V. K., Wheeler J. G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993 Dec;22(6):1154–1158. doi: 10.1093/ije/22.6.1154. [DOI] [PubMed] [Google Scholar]
  40. Rose D. N., Schechter C. B., Silver A. L. The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors. JAMA. 1986 Nov 21;256(19):2709–2713. [PubMed] [Google Scholar]
  41. Rouillon A., Perdrizet S., Parrot R. Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle. 1976 Dec;57(4):275–299. doi: 10.1016/s0041-3879(76)80006-2. [DOI] [PubMed] [Google Scholar]
  42. Snider D. E., Jr, Caras G. J. Isoniazid-associated hepatitis deaths: a review of available information. Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):494–497. doi: 10.1164/ajrccm/145.2_Pt_1.494. [DOI] [PubMed] [Google Scholar]
  43. Springett V. H., Sutherland I. BCG vaccination of schoolchildren in England and Wales. Thorax. 1990 Feb;45(2):83–88. doi: 10.1136/thx.45.2.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Stead W. W., Lofgren J. P., Warren E., Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med. 1985 Jun 6;312(23):1483–1487. doi: 10.1056/NEJM198506063122304. [DOI] [PubMed] [Google Scholar]
  45. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis. 1993 May;147(5):1311–1320. doi: 10.1164/ajrccm/147.5.1311. [DOI] [PubMed] [Google Scholar]
  46. Taylor W. C., Aronson M. D., Delbanco T. L. Should young adults with a positive tuberculin test take isoniazid? Ann Intern Med. 1981 Jun;94(6):808–813. doi: 10.7326/0003-4819-94-6-808. [DOI] [PubMed] [Google Scholar]
  47. Veening G. J. Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults. Bull Int Union Tuberc. 1968 Dec;41:169–171. [PubMed] [Google Scholar]
  48. Whalen C. C., Johnson J. L., Okwera A., Hom D. L., Huebner R., Mugyenyi P., Mugerwa R. D., Ellner J. J. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med. 1997 Sep 18;337(12):801–808. doi: 10.1056/NEJM199709183371201. [DOI] [PubMed] [Google Scholar]
  49. Yuan L., Richardson E., Kendall P. R. Evaluation of a tuberculosis screening program for high-risk students in Toronto schools. CMAJ. 1995 Oct 1;153(7):925–932. [PMC free article] [PubMed] [Google Scholar]
  50. van Geuns H. A., Meijer J., Styblo K. Results of contact examination in Rotterdam, 1967-1969. Bull Int Union Tuberc. 1975;50(1):107–121. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES